|
CBX2 expression profile based on
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| ER negative-vs-ER positive | 3.5377106264357E-111
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| HER2 Negative-vs-HER2 Positive | 2.7370431932546E-42
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| Non-TNBC tumors-vs-TNBC tumors | 4.48361316860827E-68
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| PR-Negative-vs-ER-Positive | 7.13202469214002E-75
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| Pre Menopause-vs-Post Menopause | 2.31987085778899E-09
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
| Comparison | Statistical significance |
| No Recurrence-vs-Recurred | 2.1954815908681E-06
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Grade 1-vs-Grade 2 |
4.10359437643713E-14 |
| Grade 1-vs-Grade 3 |
3.94557084714492E-98 |
| Grade 2-vs-Grade 3 |
5.89143688652739E-78 |
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| 21-40yrs-vs-41-60yrs |
2.16971679915561E-08 |
| 21-40yrs-vs-61-80yrs |
5.91241772443571E-15 |
| 21-40yrs-vs-81-100yrs |
4.29152853289384E-12 |
| 41-60yrs-vs-61-80yrs |
8.88766499983085E-07 |
| 41-60yrs-vs-81-100yrs |
4.560867E-04 |
| 61-80yrs-vs-81-100yrs |
2.900113E-01 |
|
|
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| ER-HER2- -vs- ER+ HER2- Low Prolif |
2.12400385882908E-91 |
| ER-HER2- -vs- ER+ HER2- High Prolif |
9.04944512866207E-42 |
| ER-HER2- -vs- HER2+ |
6.478768E-01 |
| ER+ HER2- Low Prolif-vs- ER+ HER2- High Prolif |
1.50410363949018E-38 |
| ER+ HER2- Low Prolif-vs- HER2+ |
6.65682715129814E-67 |
| ER+ HER2- High Prolif -vs- HER2+ |
4.53967064434065E-35 |
|
|
*
Please note that low number(<10) of samples considered.
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Stage0-vs-Stage1 |
8.746811E-01 |
| Stage0-vs-Stage2 |
8.124008E-01 |
| Stage0-vs-Stage3 |
5.036278E-01 |
| Stage0-vs-Stage4 |
7.493107E-01 |
| Stage1-vs-Stage2 |
7.88755870459102E-05 |
| Stage1-vs-Stage3 |
7.33731687231542E-06 |
| Stage1-vs-Stage4 |
7.030872E-01 |
| Stage2-vs-Stage3 |
1.127510E-02 |
| Stage2-vs-Stage4 |
2.612857E-01 |
| Stage3-vs-Stage4 |
6.726637E-02 |
|
|
*
Please note that low number(<10) of normal samples considered.
Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. Published 2016 May 10. doi:10.1038/ncomms11479
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal like-vs-LumA |
1.84988855803044E-06 |
| Normal like-vs-LumB |
1.896615E-01 |
| Normal like-vs-HER2 enriched |
3.01315297490979E-28 |
| Normal like-vs-Basal like |
7.13529052555141E-48 |
| Normal like-vs-Non Claudin |
2.984039E-01 |
| Normal like-vs-Claudin_Low |
7.18484548164347E-05 |
| LumA-vs-LumB |
1.20604540732644E-18 |
| LumA-vs-HER2 enriched |
2.19530968501384E-63 |
| LumA-vs-Basal like |
1.48089330037986E-99 |
| LumA-vs-Non Claudin |
9.341311E-01 |
| LumA-vs-Claudin_Low |
6.55006832618428E-21 |
| LumB-vs-HER2 enriched |
1.79754170732468E-33 |
| LumB-vs-Basal like |
2.10239039441156E-68 |
| LumB-vs-Non Claudin |
1.943054E-01 |
| LumB-vs-Claudin_Low |
7.160470E-04 |
| HER2 enriched-vs-Basal |
1.78156326472108E-06 |
| HER2 enriched-vs-Non Claudin |
5.172830E-03 |
| HER2 enriched-vs-Claudin_Low |
1.99205235347919E-14 |
| Basal like-vs-Non Claudin |
1.888380E-03 |
| Basal like-vs-Claudin_Low |
6.56625935382603E-33 |
| Non Claudin-vs-Claudin_Low |
6.439156E-02 |
|
|
